Concept | Assessment | Week performed |
Patient activation/ engagement | Patient Activation Measure33 34 | 1, 8*, 14 |
Arm impairment | Fugl-Meyer Assessment for upper extremity (FMA-UE)†35 36 | 1, 8*, 14 |
Arm function | Upper-Extremity Motor Activity Log-1430 | 1, 8*, 14 |
Gross level of disability | Modified Rankin Scale37 | 1, 8*, 14 |
Arm pain | Visual Analogue Scale (VAS)38 | 1, 8*, 14 |
Cognitive impairment | Montreal Cognitive Assessment‡39 40 | 1, 8*, 14 |
Arm neglect | Albert’s Test (AT)41 | 1, 8*, 14 |
Quality of life | EQ-5D-5L42 | 1, 8*, 14 |
Activity baseline | Axivity AX3 usage on both arms | 1, 14 |
System usability | System Usability Scale26 | 14 |
*Performed at week 7 during phase 2 of the study.
†Not performed during phase 2 due to inability to administer remotely.
‡A modified version was performed during phase 2.
EQ-5D-5L, EuroQol-5 Dimensions-5 Level.